MiNK Therapeutics, Inc. (INKT) vs OKYO Pharma Limited (OKYO)

A side-by-side comparison of MiNK Therapeutics, Inc. and OKYO Pharma Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
MiNK Therapeutics, Inc. logo
INKT
MiNK Therapeutics, Inc.
$60M
$12.06HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
OKYO Pharma Limited logo
OKYO
OKYO Pharma Limited
$57M
$1.49HealthcareDelayed quote: Oct 6, 2026, 12:09 PM EDT

Total return — INKT vs OKYO

growth of $100 · dividends reinvested · last 4y
INKT -2.4% (-0.6%/yr)OKYO -59.4% (-20.2%/yr)INKT compounded faster over this window
0100200300400500Start $1002023202420252026$98$41
INKT OKYO

INKT vs OKYO: by the numbers

  • •INKT is the larger company ($60M vs $57M market cap).

Metrics side by side

Valuation

MetricINKTOKYO
P/B ratioN/A4.62

Profitability

MetricINKTOKYO
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROEN/A-72.55%
ROIC-604.20%-68.91%

Go deeper

Full INKT analysisFull OKYO analysisInteractive comparison tool

Dig into the metrics

MiNK Therapeutics ROEOKYO Pharma ROEMiNK Therapeutics operating marginOKYO Pharma operating marginMiNK Therapeutics revenue growthOKYO Pharma revenue growthMiNK Therapeutics free cash flowOKYO Pharma free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.